Skip to content

Asian Pharmacoepidemiology Network

Multi-national studies for Asia

AsPEN advances pharmacoepidemiology research in Asia-Pacific to support medication safety, effectiveness evaluation, and regional education, collaboration, and knowledge exchange.

0

Countries

in Asia

0

Databases

in Asia

0M

Population

covered in Asia

0

Publications

since 2012

0

Years

of collaboration

Who we are

A regional research network

Founded in April 2012, AsPEN is a Special Interest Group of ISPE connecting pharmacoepidemiology researchers across 6+ Asia/Pacific countries.

What we do

Multi-country database studies

Common protocols applied locally to each site's claims or EHR database — rapid signal detection, methodologic harmonisation, and full pharmacoepidemiological studies.

How to join

Open to ISPE members

Join the SIG through the ISPE Community platform; new collaborators are welcomed across academic, regulatory, and industry settings.

Learn more →

Leadership

Meet the current Chair

AsPEN is led by a Chair elected from member national groups. The current Chair oversees programme strategy, ISPE liaison, and coordination of multi-country studies.

Education & Academic

Meet the Educational Lead

The Academic & Education office is the operational hub for AsPEN studies — coordinating proposals across national groups, supporting protocol development and meta-analysis, and routing industry, regulatory, and academic enquiries to the right collaborators.

Where AsPEN works

AsPEN brings together databases and research groups across Asia/Pacific. Below: a snapshot of participating data sources.